- Wolfgruber succeeds Dr. Rolf Stomberg
- Rolf Stomberg appointed as Honorary Chairman of the Supervisory Board
- Pamela Knapp joins the Supervisory Board
Cologne, June 09,2018: Dr. Matthias L. Wolfgruber (64) is the new Chairman of the Supervisory Board of LANXESS AG. At its constituent meeting, the Supervisory Board of the specialty chemicals company elected the doctor of chemistry and former CEO of Altana AG as the successor to Dr. Rolf Stomberg (78), who resigned from his office after the end of today’s Annual Stockholders’ Meeting. Wolfgruber has been a member of the Supervisory Body as a stockholder representative since 2015.
“LANXESS has undergone extensive change in recent years, and is on a stable course for growth. We aim to bring the full potential of this Group to fruition in the years ahead. In my new role, I am looking forward to continuing down our chosen path and breaking new ground in conjunction with the Board of Management and all employees,” said Wolfgruber.
On his re-election to the Supervisory Board in 2015, Stomberg had announced that he would not be serving his full term of office. However, he will maintain links with the company: At its meeting today, the newly formed Supervisory Board appointed him as its Honorary Chairman. “Rolf Stomberg helped to write LANXESS’s story chapter by chapter, and it bears his own inimitable signature. We would like to thank Dr. Stomberg for his outstanding service to the company by making him Honorary Chairman of the Supervisory Board,” added Wolfgruber.
Pamela Knapp (60) has joined the LANXESS Supervisory Board as a new member. She was elected by the stockholders at the Annual Stockholders’ Meeting held today (May 15, 2018). The economics graduate was previously CFO at the listed market-research company GFK SE in Nuremberg, Germany. Prior to that, she held various managerial roles at the Siemens Group.
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person’s officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.
LANXESS is a leading specialty chemicals company with sales of EUR 9.7 billion in 2017 and about 19,200 employees in 25 countries. The company is currently represented at 74 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. Through ARLANXEO, the joint venture with Saudi Aramco, LANXESS is also a leading supplier of synthetic rubber. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.
Corporate Comm india(CCI Newswire)